About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Anti-VEGF Therapeutics Market Size & Share forecast till 2031

Anti-VEGF Therapeutics Market

Anti-VEGF Therapeutics Market Size, Share & Trends Analysis Report By Products (Eylea, Lucentis, Beovu), By Disease (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI54734DR
Study Period 2019-2031 CAGR 0.6%
Historical Period 2019-2021 Forecast Period 2023-2031
Base Year 2022 Base Year Market Size USD 12.3 Billion
Forecast Year 2031 Forecast Year Market Size USD 13.7 Billion
Largest Market North America Fastest Growing Market Europe
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Anti-VEGF Therapeutics Market, By Products (2021-2031)
    1. Eylea
    2. Lucentis
    3. Beovu
  2. Anti-VEGF Therapeutics Market, By Disease (2021-2031)
    1. Macular Edema
    2. Diabetic Retinopathy
    3. Retinal Vein Occlusion
    4. Age-related Macular Degeneration
    1. North America
      1. North America Anti-VEGF Therapeutics Market, By Products
        1. Eylea
          1. Lucentis
            1. Beovu
            2. North America Anti-VEGF Therapeutics Market, By Disease
              1. Macular Edema
                1. Diabetic Retinopathy
                  1. Retinal Vein Occlusion
                    1. Age-related Macular Degeneration
                    2. U.S.
                      1. U.S. Anti-VEGF Therapeutics Market, By Products
                        1. Eylea
                          1. Lucentis
                            1. Beovu
                            2. U.S. Anti-VEGF Therapeutics Market, By Disease
                              1. Macular Edema
                                1. Diabetic Retinopathy
                                  1. Retinal Vein Occlusion
                                    1. Age-related Macular Degeneration
                                  2. Canada
                                2. Europe
                                  1. Europe Anti-VEGF Therapeutics Market, By Products
                                    1. Eylea
                                      1. Lucentis
                                        1. Beovu
                                        2. Europe Anti-VEGF Therapeutics Market, By Disease
                                          1. Macular Edema
                                            1. Diabetic Retinopathy
                                              1. Retinal Vein Occlusion
                                                1. Age-related Macular Degeneration
                                                2. U.K.
                                                  1. U.K. Anti-VEGF Therapeutics Market, By Products
                                                    1. Eylea
                                                      1. Lucentis
                                                        1. Beovu
                                                        2. U.K. Anti-VEGF Therapeutics Market, By Disease
                                                          1. Macular Edema
                                                            1. Diabetic Retinopathy
                                                              1. Retinal Vein Occlusion
                                                                1. Age-related Macular Degeneration
                                                              2. Germany
                                                              3. France
                                                              4. Spain
                                                              5. Italy
                                                              6. Russia
                                                              7. Nordic
                                                              8. Benelux
                                                              9. Rest of Europe
                                                            2. APAC
                                                              1. APAC Anti-VEGF Therapeutics Market, By Products
                                                                1. Eylea
                                                                  1. Lucentis
                                                                    1. Beovu
                                                                    2. APAC Anti-VEGF Therapeutics Market, By Disease
                                                                      1. Macular Edema
                                                                        1. Diabetic Retinopathy
                                                                          1. Retinal Vein Occlusion
                                                                            1. Age-related Macular Degeneration
                                                                            2. China
                                                                              1. China Anti-VEGF Therapeutics Market, By Products
                                                                                1. Eylea
                                                                                  1. Lucentis
                                                                                    1. Beovu
                                                                                    2. China Anti-VEGF Therapeutics Market, By Disease
                                                                                      1. Macular Edema
                                                                                        1. Diabetic Retinopathy
                                                                                          1. Retinal Vein Occlusion
                                                                                            1. Age-related Macular Degeneration
                                                                                          2. Korea
                                                                                          3. Japan
                                                                                          4. India
                                                                                          5. Australia
                                                                                          6. Taiwan
                                                                                          7. South East Asia
                                                                                          8. Rest of Asia-Pacific
                                                                                        2. Middle East and Africa
                                                                                          1. Middle East and Africa Anti-VEGF Therapeutics Market, By Products
                                                                                            1. Eylea
                                                                                              1. Lucentis
                                                                                                1. Beovu
                                                                                                2. Middle East and Africa Anti-VEGF Therapeutics Market, By Disease
                                                                                                  1. Macular Edema
                                                                                                    1. Diabetic Retinopathy
                                                                                                      1. Retinal Vein Occlusion
                                                                                                        1. Age-related Macular Degeneration
                                                                                                        2. UAE
                                                                                                          1. UAE Anti-VEGF Therapeutics Market, By Products
                                                                                                            1. Eylea
                                                                                                              1. Lucentis
                                                                                                                1. Beovu
                                                                                                                2. UAE Anti-VEGF Therapeutics Market, By Disease
                                                                                                                  1. Macular Edema
                                                                                                                    1. Diabetic Retinopathy
                                                                                                                      1. Retinal Vein Occlusion
                                                                                                                        1. Age-related Macular Degeneration
                                                                                                                      2. Turkey
                                                                                                                      3. Saudi Arabia
                                                                                                                      4. South Africa
                                                                                                                      5. Egypt
                                                                                                                      6. Nigeria
                                                                                                                      7. Rest of MEA
                                                                                                                    2. LATAM
                                                                                                                      1. LATAM Anti-VEGF Therapeutics Market, By Products
                                                                                                                        1. Eylea
                                                                                                                          1. Lucentis
                                                                                                                            1. Beovu
                                                                                                                            2. LATAM Anti-VEGF Therapeutics Market, By Disease
                                                                                                                              1. Macular Edema
                                                                                                                                1. Diabetic Retinopathy
                                                                                                                                  1. Retinal Vein Occlusion
                                                                                                                                    1. Age-related Macular Degeneration
                                                                                                                                    2. Brazil
                                                                                                                                      1. Brazil Anti-VEGF Therapeutics Market, By Products
                                                                                                                                        1. Eylea
                                                                                                                                          1. Lucentis
                                                                                                                                            1. Beovu
                                                                                                                                            2. Brazil Anti-VEGF Therapeutics Market, By Disease
                                                                                                                                              1. Macular Edema
                                                                                                                                                1. Diabetic Retinopathy
                                                                                                                                                  1. Retinal Vein Occlusion
                                                                                                                                                    1. Age-related Macular Degeneration
                                                                                                                                                  2. Mexico
                                                                                                                                                  3. Argentina
                                                                                                                                                  4. Chile
                                                                                                                                                  5. Colombia
                                                                                                                                                  6. Rest of LATAM

                                                                                                                                              Related Reports

                                                                                                                                              Global Report
                                                                                                                                              The global anti-inflammatory therapeutics market size was valued at USD 101.21 billion in 2021. It is projected to reach USD 141.58 billion by 2030, growing at a CAGR of 3.8% during the forecast period (2022–2030). Anti-inflammatory thera
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The global autoimmune therapeutics market size was valued at USD 71.46 billion in 2024. It is estimated to reach USD 117.43 billion by 2032, growing at a CAGR of 5.69% during the forecast period (2024–2032). The global market is primarily drive
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The Global Hepatitis B Therapeutics market size was valued at USD 4.03 billion in 2022. It is projected to reach USD 5.57 billion by 2031, growing at a CAGR of 3.65% during the forecast period (2023–2031).  The hepatitis B virus can
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The Total Addressable Market (TAM) for melanoma therapeutics was valued at USD 7.40 billion in 2022. It is projected to reach USD 18.62 billion by 2031, growing at a CAGR of 10.80% during the forecast period (2023–2031). Melanoma is a type of
                                                                                                                                              Buy Now
                                                                                                                                              Global Report
                                                                                                                                              The global peptide therapeutics market size was valued at USD 40.01 billion in 2021. It is projected to reach USD 69.93 billion by 2030, growing at a CAGR of 6.4% during the forecast period (2022–2030). Factors such as Rise of Cancer and Metabo
                                                                                                                                              Buy Now

                                                                                                                                              Purchase Benefits

                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                              • Completely customizable scope
                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                              • Dedicated account manager
                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                              • Permission to print the report

                                                                                                                                              We are featured on :

                                                                                                                                              www.straitsresearch.com
                                                                                                                                              © Copyright . All rights Reserved.